Fourier-Domain OCT in Multiple Sclerosis Patients: Reproducibility and Ability to Detect Retinal Nerve Fiber Layer Atrophy
Open Access
- 1 June 2011
- journal article
- Published by Association for Research in Vision and Ophthalmology (ARVO) in Investigative Ophthalmology & Visual Science
- Vol. 52 (7) , 4124-4131
Abstract
Purpose.: To evaluate the ability of Fourier-domain (FD) optical coherence tomography (OCT) to detect retinal nerve fiber layer (RNFL) atrophy in multiple sclerosis (MS) patients. To test the intrasession reproducibility of RNFL thickness measurements in MS and healthy subjects using Cirrus (Carl Zeiss Meditec, Dublin, CA) and Spectralis (Heidelberg Engineering, Heidelberg, Germany) OCT. Methods.: Two hundred twenty-two eyes of 111 subjects (50 MS patients and 61 healthy subjects) underwent three 360° circular scans centered on the optic disc by the same experienced examiner using the Cirrus and Spectralis OCT instruments. Differences between healthy and MS eyes were compared. The relationship between average thicknesses with each OCT was evaluated. Repeatability was studied by intraclass correlation coefficients and coefficients of variation (COV). Results.: RNFL atrophy was detected in the MS eyes for all OCT parameters (P < 0.05). Cirrus and Spectralis showed an RNFL average thickness of 99.4 and 102.5 μm, respectively, in healthy subjects, and 86.0 and 90.4 μm in the MS eyes. RNFL average thickness in the MS eyes determined by both OCTs correlated (r = 0.812; P < 0.001), but were significantly different (P < 0.001). Reproducibility was good. In the MS eyes, Cirrus measurements showed a mean COV of 5.85%, Spectralis 6.80%, and Spectralis with a progression feature 4.16%. Intraclass correlation coefficients were higher than 0.840. RNFL average thickness correlated with disease duration and an optic neuritis antecedent. Conclusions.: There are significant differences in RNFL thickness measurements between Cirrus and Spectralis despite a high correlation of measurement between the two instruments. Fourier-domain OCT can be considered a valid device for detecting RNFL atrophy in MS patients.Keywords
This publication has 37 references indexed in Scilit:
- Reproducibility of Retinal Nerve Fiber Thickness Measurements Using the Test-retest Function of Spectral OCT/SLO in Normal and Glaucomatous EyesJournal of Glaucoma, 2010
- Reproducibility of Retinal Nerve Fiber Layer and Macular Thickness Measurement with the RTVue-100 Optical Coherence TomographOphthalmology, 2010
- Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathiesNeurology, 2009
- Comparison of Retinal Nerve Fiber Layer Measurements Using Time Domain and Spectral Domain Optical Coherent TomographyOphthalmology, 2009
- Reproducibility of RTVue Retinal Nerve Fiber Layer Thickness and Optic Disc Measurements and Agreement with Stratus Optical Coherence Tomography MeasurementsAmerican Journal of Ophthalmology, 2009
- Agreement between spectral-domain and time-domain OCT for measuring RNFL thicknessBritish Journal of Ophthalmology, 2009
- Signal Strength is an Important Determinant of Accuracy of Nerve Fiber Layer Thickness Measurement by Optical Coherence TomographyJournal of Glaucoma, 2009
- Relative Course of Retinal Nerve Fiber Layer Birefringence and Thickness and Retinal Function Changes after Optic Nerve TransectionInvestigative Ophthalmology & Visual Science, 2008
- HIGH RESOLUTION FOURIER-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OF RETINAL ANGIOMATOUS PROLIFERATIONRetina, 2007
- Diagnostic accuracy of retinal abnormalities in predicting disease activity in MSNeurology, 2007